Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Double-Blind Trial of Artemisinin to Reduce The Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
In Towson
An Exploratory Study to Assess the Effects of Fanapt® on Social Cognitive Performance
This study ended early.
In ChicagoThis study evaluates the effectiveness of Bexarotene for people with schizophrenia.
This study was withdrawn before enrollment.
In Be'er Sheva, HaderaThis study has finished and is no longer accepting participants.
In BaltimoreThis study has finished and is no longer accepting participants.
In New YorkResearchers compared D Serine and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In OrangeburgThis study has finished and is no longer accepting participants.
In Baltimore
This study has finished and is no longer accepting participants.
Multiple locations, including BostonIntegrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia
This study has finished and is no longer accepting participants.
In PhiladelphiaCannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia
This study has finished and is no longer accepting participants.
In New HavenDouble Blind, Two Dose, Cross-over Clinical Trial of the Positive Allosteric Modulator at the alpha7 Nicotinic Cholinergic Receptor AVL-3288 in Schizophrenia Patients
This study has finished and is no longer accepting participants.
In New YorkClinical Trial of Dipyridamole in Schizophrenia
This study has finished and is no longer accepting participants.
In BaltimoreWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.